What Happened?
Saint Paul, MN-based Recombinetics Appointed Tammy Lee as President and Chief Executive Officer
About the Company
Recombinetics is a global leader in proprietary gene repair and gene-editing technology. Our breakthrough scientific research and development of TALEN and CRISPR (Cas9) gene editing technologies has resulted in breakthroughs in the regenerative medicine, disease research and animal agriculture.
About the Person
Tammy Lee is President and Chief Executive Officer at Recombinetics. Previously, Tammy held various senior HR leadership roles in the industry.
Info Source
News
Short Profile